CAMBRYN BIOLOGICS ANNOUNCES KEY HIRINGS OF TWO SENIOR DIRECTORS
SARASOTA, Florida – May, 2013, Mark P. Famiglio, CEO of Cambryn Biologics, a privately held Delaware corporation, announces key hirings of two senior directors.

Mr. Joseph Buettner, Director of Process Development and R & D. Mr. Buettner has over 27 years of experience in Research and Development of Biopharmaceuticals. He was formerly with Bayer’s Bio-sciences for 11 years where he supervised an R & D group. Mr. Buettner holds a master in microbiology and molecular biology and has worked on his Phd in Biochemistry.

Mr. Eric Elliott is director of Production/Manufacturing. Mr. Elliot has over 16 years of experience in plasma fractionation manufacturing . Until recently, Mr. Elliottt was principal processs development engineer at Griffols (formerly Talecris/Bayer). Mr. Elliott holds a BS in chemical engineering and an M.B.A.

The company also announces that they are on target to complete the commissioning of its facility scheduled for the early summer 2013. The facility will be cGMP compliant. Cambryn will start its conformance lots for its Hemaseel HMN and Hemaseel Thrombin products.

In April 2013, Cambryn completed its Pre-IND meeting with the US-FDA which sets the guidelines to file a new Investigative New Drug (IND) for its Hemaseel™ HMN fibrin sealant and Hemaseel™ Thrombin to be filed in 2013.

About Cambryn

Cambryn is an emerging biotherapeutic company dedicated to the development, manufacturing and commercialization of biologic products for the management and treatment of clotting factor deficiencies, advanced wound healing and biosurgical hemostats. The Company specializes in the extraction and purification of human plasma proteins. Cambryn operates a 50,000 square foot state-of-the-art cGMP facility, which incorporates cleanrooms and laboratories.

For additional information contact:
Cambryn Biologics LLC
Mark P. Famiglio
Chief Executive Officer
600 Tallevast Rd – Suite 201
Sarasota, Florida USA 34243
Office: 941-355-7400
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.cambrynbiologics.com

Cambryn Biologics LLC

Cambryn Biologics LLC is a Delaware corporation having its principal facility and offices in Sarasota, Florida. Cambryn is an emerging biotherapeutic company dedicated to the development, manufacturing and commercialization of biologic products for the management and treatment of clotting factor deficiencies.

logo small

State-of-the-Art Manufacturing Facility

Our facility consists of 50,000 square feet, located adjacent to the Sarasota/Bradenton International Airport, Sarasota, Florida, USA. Cambryn Biologics operates a state-of-the-art manufacturing facility.

Contact Details

Address: 600 Tallevast Rd.
Suite 201 Sarasota, FL 34243

Phone: (941) 355-7400

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.